Cargando…
The AF-2 cofactor binding region is key for the selective SUMOylation of estrogen receptor alpha by antiestrogens
Antiestrogens (AEs) are used to treat all stages of estrogen receptor (ER)-positive breast cancer. Selective estrogen receptor modulators such as tamoxifen have tissue-specific partial agonist activity, while selective estrogen receptor downregulators such as fulvestrant (ICI182,780) display a more...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823126/ https://www.ncbi.nlm.nih.gov/pubmed/36460099 http://dx.doi.org/10.1016/j.jbc.2022.102757 |